Φορτώνει......
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy
Colorectal cancer is the third most frequent cancer worldwide. Overall survival rates have improved greatly over the last few years due, at least in part, to the addition of targeted therapies to standard of care chemotherapy. Angiogenesis plays an important role in colorectal cancer, and therapies...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Med Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872251/ https://ncbi.nlm.nih.gov/pubmed/27239240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016635888 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|